Concepedia

Publication | Open Access

GRP78-directed immunotherapy in relapsed or refractory multiple myeloma - results from a phase 1 trial with the monoclonal immunoglobulin M antibody PAT-SM6

DOIFull Paper Access

101

Citations

29

References

2015

Year

Leo Rasche, Johannes Duell, Inês C. Castro, Valentina Dubljevic, Manik Chatterjee, Stefan Knop, Frank Hensel, Andreas Rosenwald, Hermann Einsele, Max S. Topp,
Haematologica

Abstract

clinicaltrials.gov identifier: NCT01727778.

References

YearCitations

Page 1